• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

银屑病患者肥胖问题的最新进展

Update on Obesity in Psoriasis Patients.

作者信息

Vata Dan, Tarcau Bogdan Marian, Popescu Ioana Adriana, Halip Ioana Alina, Patrascu Adriana Ionela, Gheuca Solovastru Dragos-Florin, Mocanu Madalina, Chiriac Petronela Cristina, Gheuca Solovastru Laura

机构信息

Department of Dermatology, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.

Dermatology Clinic, "St. Spiridon" County Emergency Clinical Hospital, 700111 Iasi, Romania.

出版信息

Life (Basel). 2023 Sep 22;13(10):1947. doi: 10.3390/life13101947.

DOI:10.3390/life13101947
PMID:37895330
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10608303/
Abstract

Psoriasis is a chronic inflammatory skin condition, with genetic, epigenetic, environmental, and lifestyle factors contributing to its onset and recurrence. Severe psoriasis has a great impact on quality of life, which is similar to that of insulin-dependent diabetes, depression, and ischemic heart disease, but with a lower mortality. There is an overlap between the rising incidences of autoimmune diseases and obesity. In recent years, research has shown that there is an association between psoriasis and obesity. Psoriasis is linked to obesity in a two-way manner, as each can precipitate the development of the other. Several adipose tissue-secreted adipokines were shown to be elevated in obese psoriasis patients, exhibiting similar mechanisms of action to those underlying the pathogenesis of psoriasis. Excess body weight can influence not only the treatment response in psoriasis, but also the adverse events, leading to decreased patient compliance. Specific human microbiome patterns have been identified for obesity and psoriasis and could represent a future therapeutic target in selected individuals.

摘要

银屑病是一种慢性炎症性皮肤病,其发病和复发受遗传、表观遗传、环境及生活方式等因素影响。重度银屑病对生活质量有很大影响,与胰岛素依赖型糖尿病、抑郁症及缺血性心脏病类似,但死亡率较低。自身免疫性疾病和肥胖症的发病率呈上升趋势,二者存在重叠。近年来,研究表明银屑病与肥胖症之间存在关联。银屑病与肥胖症相互关联,二者可相互诱发。肥胖的银屑病患者体内,几种脂肪组织分泌的脂肪因子水平升高,其作用机制与银屑病发病机制相似。体重超标不仅会影响银屑病的治疗反应,还会导致不良事件增加,进而降低患者的依从性。已确定肥胖症和银屑病有特定的人类微生物组模式,这可能成为特定个体未来的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc5/10608303/c7c3e6f347ec/life-13-01947-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc5/10608303/c7c3e6f347ec/life-13-01947-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc5/10608303/c7c3e6f347ec/life-13-01947-g001.jpg

相似文献

1
Update on Obesity in Psoriasis Patients.银屑病患者肥胖问题的最新进展
Life (Basel). 2023 Sep 22;13(10):1947. doi: 10.3390/life13101947.
2
Exploring the Links between Obesity and Psoriasis: A Comprehensive Review.探讨肥胖症与银屑病之间的关联:全面综述
Int J Mol Sci. 2022 Jul 6;23(14):7499. doi: 10.3390/ijms23147499.
3
Insights into Nutritional Strategies in Psoriasis.银屑病的营养策略研究进展
Nutrients. 2023 Aug 10;15(16):3528. doi: 10.3390/nu15163528.
4
New insights into different adipokines in linking the pathophysiology of obesity and psoriasis.深入了解肥胖症和银屑病病理生理学中不同脂肪因子的新见解。
Lipids Health Dis. 2019 Sep 14;18(1):171. doi: 10.1186/s12944-019-1115-3.
5
An Update on the Role of Adipose Tissues in Psoriasis.脂肪组织在银屑病中的作用研究进展。
Front Immunol. 2019 Jun 28;10:1507. doi: 10.3389/fimmu.2019.01507. eCollection 2019.
6
Compounds of psoriasis with obesity and overweight.银屑病与肥胖和超重的关联
Postepy Hig Med Dosw (Online). 2017 Aug 24;71(1):761-772. doi: 10.5604/01.3001.0010.3854.
7
Adipokines, psoriasis, systemic inflammation, and endothelial dysfunction.脂联素、银屑病、全身炎症和内皮功能障碍。
Int J Dermatol. 2017 Nov;56(11):1103-1118. doi: 10.1111/ijd.13699. Epub 2017 Aug 1.
8
Obesity in autoimmune diseases: not a passive bystander.自身免疫性疾病中的肥胖:不再是一个被动的旁观者。
Autoimmun Rev. 2014 Sep;13(9):981-1000. doi: 10.1016/j.autrev.2014.07.001. Epub 2014 Aug 2.
9
Crosstalk between skin inflammation and adipose tissue-derived products: pathogenic evidence linking psoriasis to increased adiposity.皮肤炎症与脂肪组织来源产物的相互作用:将银屑病与肥胖增加联系起来的致病证据。
Expert Rev Clin Immunol. 2016 Dec;12(12):1299-1308. doi: 10.1080/1744666X.2016.1201423. Epub 2016 Jun 27.
10
Obesity, Type 1 Diabetes, and Psoriasis: An Autoimmune Triple Flip.肥胖、1型糖尿病与银屑病:自身免疫的三重转变
Pathobiology. 2017;84(2):71-79. doi: 10.1159/000447777. Epub 2016 Sep 17.

引用本文的文献

1
Leptin: a gender and obesity-related marker predictive of metabolic comorbidities and therapeutic response to anti-IL-23 biologic drugs in psoriatic patients.瘦素:一种与性别和肥胖相关的标志物,可预测银屑病患者的代谢合并症及对抗白细胞介素-23生物药物的治疗反应。
Front Immunol. 2025 Jul 16;16:1607312. doi: 10.3389/fimmu.2025.1607312. eCollection 2025.
2
Medical Nutrition Therapy in Dermatological Diseases: A Joint Consensus Statement of the Italian Association of Dietetics and Clinical Nutrition (ADI), the Italian Society of Dermatology and Sexually Transmitted Diseases (SIDeMaST), the Italian Society of Nutraceuticals (SINut), Club Ketodiets and Nutraceuticals "KetoNut-SINut" and the Italian Society of Endocrinology (SIE), Club Nutrition, Hormones and Metabolism.皮肤病的医学营养治疗:意大利饮食与临床营养协会(ADI)、意大利皮肤病与性传播疾病学会(SIDeMaST)、意大利营养保健品学会(SINut)、酮饮食与营养保健品俱乐部“KetoNut - SINut”以及意大利内分泌学会(SIE)、营养、激素与代谢俱乐部联合共识声明
Curr Obes Rep. 2025 May 13;14(1):42. doi: 10.1007/s13679-025-00630-2.

本文引用的文献

1
Investigating Adiposity-Related Metabolic Health Phenotypes in Patients with Hidradenitis Suppurativa: A Cross-Sectional Study.化脓性汗腺炎患者中与肥胖相关的代谢健康表型调查:一项横断面研究。
J Clin Med. 2023 Jul 23;12(14):4847. doi: 10.3390/jcm12144847.
2
Metabolically Healthy Obesity Is a Misnomer: Components of the Metabolic Syndrome Linearly Increase with BMI as a Function of Age and Gender.代谢健康型肥胖是一个误称:代谢综合征的组成成分随体重指数(BMI)呈线性增加,且与年龄和性别有关。
Biology (Basel). 2023 May 15;12(5):719. doi: 10.3390/biology12050719.
3
Effects of Hypolipidemic Drugs on Psoriasis.
3
Psoriasis in Obese Adolescents with Diabetes-From Common Molecular Background to Vicious Circle of Metabolic Syndrome-Case Report and Review of Literature.肥胖青少年糖尿病患者的银屑病——从共同分子背景到代谢综合征恶性循环——病例报告及文献综述
Cells. 2025 Apr 17;14(8):610. doi: 10.3390/cells14080610.
4
BMI matters: understanding the link between weight and severe psoriasis.体重指数很重要:了解体重与重度银屑病之间的联系。
Sci Rep. 2025 Apr 1;15(1):11158. doi: 10.1038/s41598-025-94505-0.
5
Gender-related Therapeutical Response to Apremilast: New Insights in a Tailored Management of Psoriasis.阿普司特的性别相关治疗反应:银屑病个性化管理的新见解
Dermatol Pract Concept. 2025 Jan 30;15(1):4805. doi: 10.5826/dpc.1501a4805.
6
Influence of rs2280883 and rs3761548 Variants on IL-10 and TGF-β1 Serum Levels and Plaque Psoriasis Risk in the Mexican Population.rs2280883和rs3761548基因变体对墨西哥人群血清白细胞介素-10和转化生长因子-β1水平及斑块状银屑病风险的影响
Int J Mol Sci. 2025 Feb 20;26(5):1789. doi: 10.3390/ijms26051789.
7
Effects of Semaglutide Treatment on Psoriatic Lesions in Obese Patients with Type 2 Diabetes Mellitus: An Open-Label, Randomized Clinical Trial.司美格鲁肽治疗对肥胖2型糖尿病患者银屑病皮损的影响:一项开放标签、随机临床试验。
Biomolecules. 2025 Jan 1;15(1):46. doi: 10.3390/biom15010046.
8
The Role of Metabolic Syndrome in Psoriasis Treatment Response: A One-Year Comparative Analysis of PASI Progression.代谢综合征在银屑病治疗反应中的作用:一项关于银屑病面积和严重程度指数(PASI)进展的一年期比较分析
Diagnostics (Basel). 2024 Dec 23;14(24):2887. doi: 10.3390/diagnostics14242887.
9
Association between body roundness index and psoriasis among US adults: a nationwide population-based study.美国成年人身体圆润指数与银屑病的关联:一项基于全国人口的研究。
Lipids Health Dis. 2024 Nov 13;23(1):373. doi: 10.1186/s12944-024-02365-w.
10
The Intersection of the Pathogenic Processes Underlying Psoriasis and the Comorbid Condition of Obesity.银屑病潜在致病过程与肥胖合并症的交集
Life (Basel). 2024 Jun 7;14(6):733. doi: 10.3390/life14060733.
降血脂药物对银屑病的影响。
Metabolites. 2023 Mar 29;13(4):493. doi: 10.3390/metabo13040493.
4
Efficacy of Semaglutide in Treating Obesity: A Systematic Review of Randomized Controlled Trials (RCTs).司美格鲁肽治疗肥胖症的疗效:随机对照试验(RCT)的系统评价
Cureus. 2022 Dec 16;14(12):e32610. doi: 10.7759/cureus.32610. eCollection 2022 Dec.
5
Psoriasis Management Challenges Regarding Difficult-to-Treat Areas: Therapeutic Decision and Effectiveness.银屑病在难治疗部位的管理挑战:治疗决策与有效性
Life (Basel). 2022 Dec 7;12(12):2050. doi: 10.3390/life12122050.
6
A Randomized Open-Label Clinical Trial of Lipid-Lowering Therapy in Psoriasis to Reduce Vascular Endothelial Inflammation.一项关于银屑病降脂治疗以减轻血管内皮炎症的随机开放标签临床试验。
J Invest Dermatol. 2022 Jun;142(6):1749-1752.e4. doi: 10.1016/j.jid.2021.07.190. Epub 2021 Nov 19.
7
Meta-Inflammation and Metabolic Reprogramming of Macrophages in Diabetes and Obesity: The Importance of Metabolites.糖尿病与肥胖症中巨噬细胞的代谢炎症与代谢重编程:代谢物的重要性
Front Immunol. 2021 Nov 5;12:746151. doi: 10.3389/fimmu.2021.746151. eCollection 2021.
8
Impact of Body Mass Index on the Efficacy of Biological Therapies in Patients with Psoriasis: A Real-World Study.体重指数对银屑病患者生物疗法疗效的影响:一项真实世界研究。
Clin Drug Investig. 2021 Oct;41(10):917-925. doi: 10.1007/s40261-021-01080-z. Epub 2021 Sep 18.
9
Two birds one stone: semaglutide is highly effective against severe psoriasis in a type 2 diabetic patient.一石二鸟:司美格鲁肽对一名2型糖尿病患者的重度银屑病疗效显著。
Endocrinol Diabetes Metab Case Rep. 2021 Aug 1;2021. doi: 10.1530/EDM-21-0007.
10
Metabolic Syndrome and Psoriasis: Mechanisms and Future Directions.代谢综合征与银屑病:机制及未来方向
Front Immunol. 2021 Jul 23;12:711060. doi: 10.3389/fimmu.2021.711060. eCollection 2021.